open access

Vol 66, No 5 (2016)
Review articles
Published online: 2017-03-29
Get Citation

Review of Polish and international guidelines on hormonal therapy in localized prostate cancer

Ewa Pawłowska, Jacek Jassem
DOI: 10.5603/NJO.2016.0071
·
Nowotwory. Journal of Oncology 2016;66(5):403-407.

open access

Vol 66, No 5 (2016)
Review articles
Published online: 2017-03-29

Abstract

Prostate cancer is the second most common male malignancy in Poland. We present guidelines of Polish and international oncology and urology societies on hormonal therapy for localized prostate cancer.

Abstract

Prostate cancer is the second most common male malignancy in Poland. We present guidelines of Polish and international oncology and urology societies on hormonal therapy for localized prostate cancer.

Get Citation

Keywords

prostate cancer, hormonal treatment, guidelines

About this article
Title

Review of Polish and international guidelines on hormonal therapy in localized prostate cancer

Journal

Nowotwory. Journal of Oncology

Issue

Vol 66, No 5 (2016)

Pages

403-407

Published online

2017-03-29

DOI

10.5603/NJO.2016.0071

Bibliographic record

Nowotwory. Journal of Oncology 2016;66(5):403-407.

Keywords

prostate cancer
hormonal treatment
guidelines

Authors

Ewa Pawłowska
Jacek Jassem

References (11)
  1. Wojciechowska U, Didkowska J. Zachorowania i zgony na nowotwory złośliwe w Polsce. Centrum Onkologii — Instytut im. Marii Skłodowskiej-Curie: Krajowy Rejestr Nowotworów. . http://onkologia.org.pl/raporty// (11.01.2016).
  2. Trama A, Foschi R, Larrañaga N, et al. Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 study. European Journal of Cancer. 2015; 51(15): 2206–2216.
  3. http://www.onkologia.zalecenia.med.pl/pdf/PTOK_2013_07_Nowotwory%20ukladu%20 moczowo-plciowego.pdf..
  4. http://uroweb.org/wp-content/uploads/EAU-Guidelines-Prostate-Cancer-2015-v2.pdf..
  5. http://www.auanet.org/common/pdf/education/clinical-guidance/ /Prostate-Cancer.pdf.
  6. https://annonc.oxfordjournals.org/content/26/suppl_5/v69.full.pdf+html.
  7. http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf.
  8. http://www.nice.org.uk/guidance/cg175/chapter/1-recommendations.
  9. Morote J, Planas J, Salvador C, et al. Individual variations of serum testosterone in patients with prostate cancer receiving androgen deprivation therapy. BJU Int. 2009; 103(3): 332–335.
  10. Cookson MS, Aus G, Burnett AL, et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol. 2007; 177(2): 540–545.
  11. Roach M, Hanks G, Thames H, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006; 65(4): 965–974.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl